Skip to main content

SenesTech Inc. (NASDAQ: SNES) Offers a Sustainable and Environmentally-Friendly Solution to the Growing Rodent Problem where Poisons and Traps Have Failed

  • SenesTech, a rodent fertility control product provider and the inventor of the only EPA-registered contraceptive for male and female rats, is offering a sustainable and proactive tool  in the fight against rodent pests
  • With New York City reporting an estimated 3 million rats as one of the top five list of the most rat-infested cities in the U.S., it paints a grim picture of the situation at hand
  • SenesTech’s Evolve(TM) soft bait products for both rats and mice has been scientifically proven to manage rodent infestations, allowing for a superior proactive approach to addressing the rodent problem
  • The product was developed as a minimum risk product as defined by the EPA, posing little or no harm to the environment, people, or non-targeted animals such as birds of prey and cats

In 2023, it was estimated that New York City had roughly 3 million rats, an increase of almost 1 million over the last ten years. The situation has gotten so bad that the city has become almost synonymous with rat infestation problems.

This statistic paints an astonishing picture of the rodent problem in the U.S., and the need to better address it sustainably and effectively. SenesTech (NASDAQ: SNES), a rodent fertility control product provider and the inventor of the only EPA-registered contraceptive for male and female rats, promises…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to SNES are available in the company’s newsroom at https://ibn.fm/SNES

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
Editor@InvestorWire.com

InvestorWire is powered by IBN

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.